Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03549338
Title Sym004 Versus Futuximab or Modotuximab in Patients With mCRC
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Symphogen A/S
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | ESP | DEU

Facility Status City State Zip Country Details
City of Hope - Comprehensive Cancer Center Duarte California 91010 United States Details
Emory University Hospital Atlanta Georgia 30322 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
University of North Carolina - Lineberger Comprehensive Cancer Center Chapel Hill North Carolina 27599 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Uniklinik Dresden Dresden 01307 Germany Details
Universitaetsklinikum Essen Essen 45147 Germany Details
Asklepios Kliniken Altona Hamburg 22763 Germany Details
Universitätsmedizin Mannheim Mannheim 68167 Germany Details
Städtisches Klinikum München München 81737 Germany Details
ASST Grande Ospedale Metropolitano Niguarda Milano 20162 Italy Details
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" Napoli 80131 Italy Details
Università degli Studi della Campania "Luigi Vanvitelli" Napoli 80131 Italy Details
Hospital del Mar Barcelona 08003 Spain Details
Vall d'Hebron Institut d'Oncologia (VHIO) Barcelona 08035 Spain Details
Institut Català d'Oncologia Barcelona 08908 Spain Details
Hospital Universitario HM Sanchinarro Madrid 28050 Spain Details
Hospital Clínico de Valencia Valencia 46010 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field